Citigroup
CBST

Citigroup’s CUBIST PHARMACEUTICALS INC CBST Stock Holding History

Citigroup’s Portfolio CBST Stock Details CBST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-102,351
Closed -$10.3M – 7777
2014
Q4 		$10.3M Buy
102,351
+98,276
+2,412% +$7.64M 0.01% 1251
2014
Q3 		$270K Sell
4,075
-10,276
-72% -$675K ﹤0.01% 4020
2014
Q2 		$1M Sell
14,351
-14,413
-50% -$980K ﹤0.01% 2974
2014
Q1 		$2.1M Sell
28,764
-50,079
-64% -$3.73M ﹤0.01% 2322
2013
Q4 		$5.43M Buy
78,843
+29,376
+59% +$1.9M ﹤0.01% 1741
2013
Q3 		$3.14M Buy
49,467
+43,197
+689% +$2.61M ﹤0.01% 2142
2013
Q2 		$304K Buy
+6,270
New +$308K ﹤0.01% 3911

Citigroup's CBST Position: Q1 2015 in Review

Citigroup sold out of CUBIST PHARMACEUTICALS INC (CBST) in Q1 2015, closing a stake of 102,351 shares — an estimated $10.3M sold.

Citigroup first reported a position in CBST in Q2 2013 and held it in 7 quarters. The position peaked at $10.3M in Q4 2014. 0 funds tracked by Wall St. Rank hold CBST as of Q1 2015.

  • Citigroup reported no remaining CUBIST PHARMACEUTICALS INC position as of Q1 2015 after selling out during the quarter.
  • Citigroup sold 102,351 CUBIST PHARMACEUTICALS INC shares in Q1 2015, an estimated $10.3M.
  • Citigroup first reported a position in CUBIST PHARMACEUTICALS INC in Q2 2013 and held it in 7 quarters.
  • Citigroup's CUBIST PHARMACEUTICALS INC position peaked at $10.3M in Q4 2014.
  • 0 funds tracked by Wall St. Rank held CUBIST PHARMACEUTICALS INC as of Q1 2015.

Based on Citigroup's 13F filing for Q1 2015, filed 14 May 2015.